Dovato 50 mg/1
dolutegravir sodium and lamivudine · TABLET, FILM COATED · ViiV Healthcare Company
Dovato is a tablet, film coated containing dolutegravir sodium and lamivudine at 50 mg/1, taken oral. Manufactured by ViiV Healthcare Company.
Key Facts
- Brand Name
- Dovato
- Generic Name
- dolutegravir sodium and lamivudine
- NDC Code (Product)
49702-246- Manufacturer
- ViiV Healthcare Company
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA211994
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 04/08/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Dovato used for?
Dovato contains dolutegravir sodium and lamivudine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Dovato a controlled substance?
Dovato is not classified as a controlled substance by the DEA.
What is the generic name for Dovato?
The generic name for Dovato is dolutegravir sodium and lamivudine. There are no other listed brand versions of dolutegravir sodium and lamivudine.
What is the NDC code for Dovato 50 mg/1?
The NDC (National Drug Code) for Dovato 50 mg/1 is 49702-246, listed by ViiV Healthcare Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)